Galera Therapeutics Inc.
0.05
0.00 (5.26%)
At close: Jan 15, 2025, 3:30 PM
0.05
0.87%
Pre-market Jan 10, 2025, 09:30 AM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Revenue n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue 259.00K 114.00K 778.00K 368.00K 267.00K 127.00K 84.00K
Gross Profit -259.00K -114.00K -778.00K -368.00K -267.00K -127.00K -84.00K
Operating Income -46.95M -51.23M -73.37M -70.55M -50.69M -24.25M -24.09M
Interest Income 9.82M 506.00K 32.00K 1.17M 1.82M 606.00K 193.00K
Pretax Income -59.08M -62.29M -80.53M -74.23M -51.94M -23.90M -23.91M
Net Income -59.08M -62.22M -87.73M -74.22M -51.93M -23.68M -23.55M
Selling & General & Admin 22.84M 20.21M 20.95M 15.71M 8.36M 5.59M 3.50M
Research & Development 24.11M 31.01M 52.42M 54.84M 42.33M 18.66M 20.59M
Other Expenses n/a -11.07M -7.17M -3.68M -1.25M n/a n/a
Operating Expenses 46.69M 51.23M 73.37M 70.55M 50.69M 24.25M 24.09M
Interest Expense n/a 11.57M 7.19M 4.88M 3.03M 220.00K n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 46.95M 51.23M 73.37M 70.55M 50.69M 24.25M 24.09M
Income Tax n/a -70.00K 7.19M -16.00K -9.00K -223.00K -360.00K
Shares Outstanding (Basic) 44.55M 27.09M 25.79M 24.87M 24.81M 19.36M 15.22M
Shares Outstanding (Diluted) 44.55M 27.09M 25.79M 24.87M 24.81M 19.36M 15.22M
EPS (Basic) -1.33 -2.3 -3.4 -2.98 -2.09 -1.22 -1.55
EPS (Diluted) -1.33 -2.3 -3.4 -2.98 -2.09 -1.22 -1.55
EBITDA -46.69M -50.61M -72.56M -69.01M -50.69M -23.52M -23.82M
Depreciation & Amortization 259.00K 114.00K 778.00K 368.00K 267.00K 127.00K 84.00K

Create Price Alert on GRTX

Your price alert will notify you when the stock price is above 0.05.

Add to Watchlist